Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Economic Modelling of Screen-and-Treat Strategies for Brazilian Women at Risk of Hereditary Breast and Ovarian Cancer
Julia Simões Corrêa Galendi, Maria Del Pilar Estevez Diz, Stephanie Stock, et al.
Applied Health Economics and Health Policy (2020) Vol. 19, Iss. 1, pp. 97-109
Open Access | Times Cited: 19

Showing 19 citing articles:

The Cost Effectiveness of Genomic Medicine in Cancer Control: A Systematic Literature Review
Mackenzie Bourke, Aideen M. McInerney‐Leo, Julia Steinberg, et al.
Applied Health Economics and Health Policy (2025)
Open Access | Times Cited: 1
The role of genomics in global cancer prevention
Ophira Ginsburg, Patrícia Ashton‐Prolla, Anna Cantor, et al.
Nature Reviews Clinical Oncology (2020) Vol. 18, Iss. 2, pp. 116-128
Closed Access | Times Cited: 34
Economic evaluation of germline genetic testing for breast cancer in low- and middle-income countries: a systematic review
S. Goh, Siew Chin Ong, Jue Ern Chan
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 4
Why is appropriate healthcare inaccessible for many European breast cancer patients? – The EBCC 12 manifesto
Fátima Cardoso, Fiona MacNeill, Frédérique Penault‐Llorca, et al.
The Breast (2021) Vol. 55, pp. 128-135
Open Access | Times Cited: 25
Cost-Effectiveness of Targeted Genetic Testing for Breast and Ovarian Cancer: A Systematic Review
Andreas Koldehoff, Marion Danner, Daniele Civello, et al.
Value in Health (2021) Vol. 24, Iss. 2, pp. 303-312
Open Access | Times Cited: 23
Cost-Effectiveness of BRCA 1/2 Genetic Test and Preventive Strategies: Using Real-World Data From an Upper-Middle Income Country
Marina Lourenç�ão, Julia Simões Corrêa Galendi, Henrique de Campos Reis Galvão, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 12
Population or family history based BRCA gene tests of breast cancer? A systematic review of economic evaluations
Zahra Meshkani, Ali Aboutorabi, Najmeh Moradi, et al.
Hereditary Cancer in Clinical Practice (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 15
Uptake Rates of Risk-Reducing Surgeries for Women at Increased Risk of Hereditary Breast and Ovarian Cancer Applied to Cost-Effectiveness Analyses: A Scoping Systematic Review
Julia Simões Corrêa Galendi, Sibylle Kautz‐Freimuth, Stephanie Stock, et al.
Cancers (2022) Vol. 14, Iss. 7, pp. 1786-1786
Open Access | Times Cited: 10
Direct Medical Costs, Productivity Loss Costs and Out-Of-Pocket Expenditures in Women with Breast Cancer in Latin America and the Caribbean: A Systematic Review
Alfredo Palacios, Carlos Rojas‐Roque, Lucas González, et al.
PharmacoEconomics (2021) Vol. 39, Iss. 5, pp. 485-502
Closed Access | Times Cited: 13
Economic evaluations of predictive genetic testing: A scoping review
Qin Xi, Shihan Jin, Stephen Morris
PLoS ONE (2023) Vol. 18, Iss. 8, pp. e0276572-e0276572
Open Access | Times Cited: 4
Cost-effectiveness of stereotactic body radiotherapy versus conventional radiotherapy for the treatment of surgically ineligible stage I non-small cell lung cancer in the Brazilian public health system
Gustavo Viani Arruda, Marina Lourenç�ão, Jorge Henrique Caldeira de Oliveira, et al.
The Lancet Regional Health - Americas (2022) Vol. 14, pp. 100329-100329
Open Access | Times Cited: 5
Risk factors associated with COVID-19-induced death in patients hospitalized in intensive care units (ICUs) in a city in Southern Brazil
André Silva Olak, Aline M. Susuki, Milena Kanashiro, et al.
Toxicology Reports (2021) Vol. 8, pp. 1565-1568
Open Access | Times Cited: 6
Importance of genetic cancer risk assessment as a strategy to stratify risk and provide precision prevention in high-risk patients and families
Patrícia Ashton‐Prolla, Maria Isabel Achatz, Miguel Ângelo Martins Moreira, et al.
Revista da Associação Médica Brasileira (2024) Vol. 70, Iss. suppl 1
Open Access
GASTOS DO SISTEMA PÚBLICO DE SAÚDE COM TRATAMENTO EM ONCOLOGIA
Helen Maria da Silva Gomes, João Carlos Hipólito Bernardes do Nascimento, Anderson Rafael Costa Sousa, et al.
RAHIS - Revista de Administração Hospitalar e Inovação em Saúde (2021) Vol. 18, Iss. 2, pp. 74-89
Open Access | Times Cited: 3
Data on Utility in Cost–Utility Analyses of Genetic Screen-and-Treat Strategies for Breast and Ovarian Cancer
Julia Simões Corrêa Galendi, Vera Vennedey, Hannah Kentenich, et al.
Cancers (2021) Vol. 13, Iss. 19, pp. 4879-4879
Open Access | Times Cited: 2
Evolution of COVID-19 in Londrina (State of Paraná – Brazil) between March and August of 2020
Aline M. Susuki, André Silva Olak, Ana Luiza Favarão Leão, et al.
Semina Ciências Exatas e Tecnológicas (2021) Vol. 42, Iss. 1Supl, pp. 5-5
Open Access | Times Cited: 2
Hereditary determinants of gynecological cancer and recommendations
Jesus Paula Carvalho, Filomena Marino Carvalho, Anisse Marques Chami, et al.
Revista Brasileira Ginecologia e Obstetrícia (2021) Vol. 43, Iss. 08, pp. 638-643
Open Access | Times Cited: 1
Is BRCA1/2 testing for women at high cancer risk cost effective in Brazil?

PharmacoEconomics & Outcomes News (2020) Vol. 856, Iss. 1, pp. 18-18
Closed Access
Avaliação in vitro das propriedades biológicas do extrato de sementes de Eschweilera ovata (Cambess.) Miers
Nathália Araújo Rocha
(2021)
Open Access
Page 1

Scroll to top